• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[科多尔省食管癌情况]

[Cancer of the esophagus in the department of Côte-d'Or].

作者信息

Bedenne L, Faivre J, Boutron M C, Hillon P, Milan C, Riou F, Klepping C

出版信息

Bull Cancer. 1986;73(5):526-34.

PMID:3779134
Abstract

The registry of digestive tract tumors established for the department of Côte-d' Or was used to study the incidence and characteristics of oesophageal cancer in the area. The crude annual incidence rate was 15.5/100,000 for males, ans 1.1/100,000 for females. The corresponding age standardized rate (world standard) were 12.7 and 0.6. The sex ratio was 21.2. As compared to other cancer registries the Côte-d' Or is in intermediate range for males, in the low range for females. The incidence of oesophageal cancer was similar in urban and rural areas. The risk of oesophageal cancer in males was five times higher in workers than in high executives and professionals. There was no significant variation in oesophageal cancer incidence over the 8 years of the study. Rates tended to decrease slightly in both sexes. Most cancers were squamous cell carcinomas (92%). Adenocarcinomas represented 5% of the cases. The risk of an associated tumour of the upper respiratory and digestive tract was important (17.5%). Only 10.4% of the patients underwent curative surgery, while 53.4% were referred for radiotherapy alone. The overall 1-year survival rate was 18.4%, and the 5-year survival rate was 2.8%. The 5-year survival rate was 7.2% after curative surgery, and 3.2% after radiotherapy. These results underline the fact that the prognosis of oesophageal cancer in a well defined population where only one patient out of ten can benefit from curative surgery, remains poor.

摘要

为科多尔省设立的消化道肿瘤登记处用于研究该地区食管癌的发病率和特征。男性的年粗发病率为15.5/10万,女性为1.1/10万。相应的年龄标准化率(世界标准)分别为12.7和0.6。性别比为21.2。与其他癌症登记处相比,科多尔省男性发病率处于中等范围,女性处于低范围。食管癌的发病率在城市和农村地区相似。男性工人患食管癌的风险比高级管理人员和专业人员高五倍。在研究的8年中,食管癌发病率没有显著变化。两性发病率均有轻微下降趋势。大多数癌症为鳞状细胞癌(92%)。腺癌占病例的5%。上呼吸道和消化道相关肿瘤的风险较高(17.5%)。只有10.4%的患者接受了根治性手术,而53.4%的患者仅接受了放射治疗。总体1年生存率为18.4%,5年生存率为2.8%。根治性手术后5年生存率为7.2%,放射治疗后为3.2%。这些结果突显了这样一个事实,即在一个明确界定的人群中,食管癌的预后仍然很差,每十名患者中只有一名能够从根治性手术中获益。

相似文献

1
[Cancer of the esophagus in the department of Côte-d'Or].[科多尔省食管癌情况]
Bull Cancer. 1986;73(5):526-34.
2
[Cancer of the gallbladder in the Côte d'Or].[科多尔省的胆囊癌]
Gastroenterol Clin Biol. 1987 Mar;11(3):237-41.
3
[Epidemiology of cancers of the small intestine. Evaluation of 10 years' registration at the Cote-d'Or department].[小肠癌的流行病学。科多尔省十年登记情况评估]
Bull Cancer. 1988;75(8):751-6.
4
[Colorectal cancer in the Department of Côte-d'Or].[科多尔省的结直肠癌]
Bull Cancer. 1984;71(1):50-6.
5
[Incidence, diagnosis, treatment and prognosis of cancer of the pancreas: development in Côte-d'Or from 1976 to 1985].[胰腺癌的发病率、诊断、治疗及预后:1976年至1985年科多尔省的情况]
Bull Cancer. 1991;78(4):323-30.
6
Primary liver cancer in Cote d'Or (Burgundy). Results of three year's systematic registration in a well defined French population.科多尔省(勃艮第大区)的原发性肝癌。在法国一个明确界定的人群中进行三年系统登记的结果。
Biomedicine. 1979 Sep;31(5):150-2.
7
[Incidence of chronic lymphocytic leukemia in the Department of Côte-d'Or].[科多尔省慢性淋巴细胞白血病的发病率]
Nouv Rev Fr Hematol (1978). 1986;28(1):23-6.
8
[Esophageal cancer at the department of Calvados. Geographic and social inequality factors].[卡尔瓦多斯省食管癌。地理和社会不平等因素]
Bull Cancer. 1989;76(10):1111-9.
9
Cancer of the esophagus. An incidence study of Côte d'Or (Burgundy).食管癌。科多尔省(勃艮第大区)的发病率研究。
Oncology. 1981;38(1):1-3. doi: 10.1159/000225510.
10
[Malpighian cancer of the anal canal in Côte-d'Or. Epidemiological and therapeutic aspects].[科多尔省肛管的马尔皮基氏癌。流行病学和治疗方面]
Bull Cancer. 1985;72(6):483-90.

引用本文的文献

1
Neoadjuvant chemoradiotherapy could improve survival outcomes for esophageal carcinoma: a meta-analysis.新辅助放化疗可改善食管癌患者的生存结局:一项荟萃分析。
Dig Dis Sci. 2012 Dec;57(12):3226-33. doi: 10.1007/s10620-012-2263-8. Epub 2012 Jun 14.